\begin{table}[h]
  \centering
  \captionof{table}{
    Drugs used in this study, their MICs, working concentrations, and stock solvents.
    In the MIC column, we report the highest concentration of the dilution series (numerator) and the maximum inhibiting dilution (denominator).
    Kanamycin (\SI{50}{\micro\gram\per\milli\liter}) was used as the selection marker for the \textit{lux} operon.
  }
  \input{chapter_3sup/tables/drug_table}
  \label{tab:drugs}
\end{table}

\begin{table}
  \captionof{table}{
    Point estimates and 95\% percentile intervals of $\psi_\mathrm{CFU}$, $\psi_I$, $\psi_I^*$, and $\psi_J$ for different treatments.
    Sig$_X$ indicates whether the rate of change of signal $X \in \{I, I^*, J\}$ differs significantly (*) from the distribution of $\psi_\mathrm{CFU}$, or not (n.s.), based on the significance criterion defined in the Methods section.
    Estimates are based on data from the CFU-luminescence assays (see Methods).
  }
  \setlength{\tabcolsep}{3pt}
  \input{chapter_3sup/tables/comparison_table}
  \label{tab:comp_stats}
\end{table}

\begin{table}
  \centering
  \captionof{table}{
    Bootstrapped 95\% confidence intervals and point estimates for the length, width, and volume of cells after 2\,h of treatment, estimated from microscopy images.
  Significance was assessed by comparing the confidence intervals of cell volumes for each antibiotic treatment to the untreated control (\texttt{control\_2h}), as described in the Methods section of the main paper.}

  \setlength{\tabcolsep}{3pt}
  \renewcommand{\arraystretch}{1.75}
  \input{chapter_3sup/tables/morph_post}
  \label{tab:morph_post}
\end{table}
\vspace{3cm}

\begin{table}
  \centering
  \captionof{table}{
    Estimated group means and $95\%$ confidence intervals from an ordinary least squares (OLS) model fitted to log-transformed CFU data, collected from the first sampled time point after diluting pexiganan-treated strains in supplemented PBS.
    Grouping is based on the supplement (\ce{CaCl2} or \ce{MgCl2}) and concentration (\SIrange{0}{100}{\milli M}).
    Confidence intervals were computed using heteroscedasticity-consistent standard errors (HC3).
  The compact letter display (cld) indicates groups that are not significantly different by sharing a common letter, based on mutual inclusion of their $95\%$ confidence intervals.}
  \input{chapter_3sup/tables/group_summary}
  \label{tab:pbs_ols}
\end{table}

\begin{table}
  \centering
  \captionof{table}{Comparison of kill rates [$h^{-1}$] between cultures treated with pexiganan (\SI{16}{\micro\gram\per\milli\liter}) for 5 minutes and cultures exposed to the supernatant collected after the kill assay.
  The two rates differ significantly; the confidence interval of the rate of change of CFU in the supernatant includes zero.}
  \input{chapter_3sup/tables/supernatant}
  \label{tab:supernatant}
\end{table}

\begin{table}
  \centering
  \captionof{table}{Primer sequences used for $\lambda$-red mediated integration of the \emph{luxCDABE} operon into \textit{E. coli}.
  Lowercase letters indicate homology regions binding to the \emph{lux} operon on the plasmid; uppercase letters indicate chromosomal homology regions at the integration site.}

  \label{tab:primers}
  \begin{tabular}{ll}
    \toprule
    Primer name & Sequence (5' $\rightarrow$ 3')\\
    \midrule
    forward primer & CGGTACGGCTGACCATCGGGTGCCAGTGCGGGAGTTTCGT\textbf{acccagtaaggcagcggtatc}\\
    reverse primer & AGTCAGCGATATCCATTTTCGCGAATCCGGAGTGTAAGAA\textbf{taggtctagggcggcgga}\\
    \bottomrule
  \end{tabular}
  \vspace{2cm}
\end{table}